Type-2-Diabetes: Canagliflozin reduces cardiovascular Risk

被引：0

|

作者：

Lichert, Frank

机构：

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期

关键词：

D O I：

10.1056/NEJMoa.1611925

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1647 / 1647

页数：1

相关论文

共 50 条

[21] How high is the Mortality Risk for Type-2-Diabetes?
不详
NEPHROLOGE, 2016, 11 (06): : 380 - 380
[22] Finerenone improves renal and cardiovascular Prognosis in Type-2-Diabetes
Franke, Katharina
AKTUELLE KARDIOLOGIE, 2022, 11 (04)
[23] Obesity in Childhood as a Risk Factor for Type-2-Diabetes
Pavlicek, Vojtech
DIABETOLOGE, 2018, 14 (05): : 342 - 343
[24] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Reply
Neal, Bruce
Perkovic, Vlado
Matthews, David R.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2099 - 2099
[25] Gene Type-2-Diabetes A Portal helps to understand Type-2-Diabetes better
不详
DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (04): : 258 - 258
[26] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES BASED ON HISTORY OF CARDIOVASCULAR DISEASE OR CARDIOVASCULAR RISK FACTORS
Davies, Michael J.
Merton, Katherine
Vijapurkar, Ujjwala
Cuffee, Maurice
Yee, Jacqueline
Qiu, Rong
JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S176 - S176
[27] Efficacy and Safety of Canagliflozin in Patients With Type 2 Diabetes Based on History of Cardiovascular Disease or Cardiovascular Risk Factors
Davies, Michael J.
Merton, Katherine
Vijapurkar, Ujjwala
Yee, Jacqueline
Qiu, Rong
CIRCULATION, 2016, 134
[28] Pioglitazone reduces blood pressure in patients with type-2-diabetes mellitus
Scherbaum, W
Göke, B
DIABETES, 2001, 50 : A462 - A462
[29] Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients
Chen, Xiaoyu
Shu, Yimin
Lin, Xuebo
DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
[30] The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
Carbone, Salvatore
Dixon, Dave L.
CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)

← 1 2 3 4 5 →